Population clinical pharmacology of children: general principles
- 29 June 2006
- journal article
- review article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 165 (11) , 741-746
Abstract
Population modelling using mixed-effects models provides a means to study variability in drug responses among individuals representative of those for whom the drug will be used clinically. The advantages of these models in paediatric studies are that they can be used to analyse sparse data, sampling times are not crucial and can be fitted around clinical procedures and individuals with missing data may still be included in the analysis. The introduction of explanatory covariates explains the predictable part of the between-individual variability. Simulations using parameter estimates and their variability can be used to investigate large numbers of children – many more than is possible in studies dealing with real children – for a fraction of the cost, which is an advantage when developing clinical trials. Paediatric population modelling has expanded greatly in the past decade and is now a routine procedure during the development and investigation of drugs. Children have benefitted and will continue to benefit from this approach.Keywords
This publication has 45 references indexed in Scilit:
- What the paediatricians need?the launch of paediatric research in EuropeEuropean Journal of Pediatrics, 2005
- Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathyThe Journal of Pediatrics, 1995
- Fentanyl, fads, and folly: Who will adopt the therapeutic orphans?The Journal of Pediatrics, 1991
- Population PharmacokineticsClinical Pharmacokinetics, 1986
- Extended least squares nonlinear regression: A possible solution to the “choice of weights” problem in analysis of individual pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1984
- Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: Routine clinical pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1983
- Steady-state Pharmacokinetics of Phenytoin from Routinely Collected Patient Data???Clinical Pharmacokinetics, 1983
- Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1980
- Estimation of population characteristics of pharmacokinetic parameters from routine clinical dataJournal of Pharmacokinetics and Biopharmaceutics, 1977